According to our latest research, the global prosthetic joint infections treatment market size reached USD 2.59 billion in 2025, reflecting the growing incidence of joint replacement procedures and subsequent infection risks worldwide. The market is expanding at a robust CAGR of 7.6% and is forecasted to reach approximately USD 5.02 billion by 2034. This growth is primarily propelled by the increasing prevalence of prosthetic joint surgeries, the rising geriatric population, and rapid advancements in infection management protocols. The ongoing development of novel antibiotics and minimally invasive surgical techniques is also contributing significantly to the market's upward trajectory through the 2026-2034 forecast period.

growthmarketreports.com/repo...